Login

Financial Snapshot

Revenue
TTM
$458.7M
Gross Margin
TTM
64.56%
Net Income
TTM
$11.69M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
385.67%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$450.5M
Cash
2026 Q1
P/E
TTM
84.81
Free Cash Flow
TTM
$14.58M

Stock Price

Loading...
Market Cap: $991.25 Million

About Artivion Inc

Artivion Inc (NASDAQ: AORT) is a medical device and tissue processing company focused on cardiac and vascular surgery products. The filing excerpts provided do not contain sufficient detail to describe Artivion's revenue model, segment breakdown, product lines, geographic footprint, competitive position, or financial metrics beyond the company name and ticker. All fields below reflect only what the supplied 10-K excerpt supports.

Source: SEC 10-K, filed 2026-02-18

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Senseonics Holdings Inc AxoGen Inc Cardiovascular Systems Inc Cue Health Inc. Outset Medical Inc Inogen Inc Mesa Laboratories Inc ViewRay, Inc. SI-BONE Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support